206 search results for “drug delivery” in the Student website
-
national survey on mental well-being, alcohol and drug use
Social
-
How Oncode-PACT is bringing new cancer medicines closer with 325 million in Growth Fund money
How can you ensure that more experimental drugs reach the finish line? At the moment, only one in twenty cancer drugs that are tested on humans makes it to the market. This is an enormous loss for patients and society. With a grant from the National Growth Fund, Oncode-PACT aims to efficiently select…
-
Steffen Brünle
Science
s.bruenle@lic.leidenuniv.nl | +31 71 527 4544
-
Agreements
Read here about the various agreements in place at Leiden University for student and study associations and other student organisations.
-
Gorlaeus Faculty Office
Einsteinweg 55, Leiden
-
Gravensteen
Pieterskerkhof 6, Leiden
-
Dies Natalis all about innovating and connecting
‘We could share our knowledge more with others and apply it more widely,’ said Annetje Ottow, President of the Executive Board, while presenting the new Strategic Plan on the University’s 447th Dies Natalis. The new Strategic Plan therefore focuses on innovating and connecting, among disciplines and…
-
Medical Delta AI for Computational Life Sciences
The fact that scientists are increasingly better able to access molecular cell and tissue data also brings with it a new challenge: how can scientists find the information they need for research among the vast amount of data available?
-
How to develop cancer drugs with less side effects
Lecture, Tuesday Talks: Science Insights
-
Madouc Bergers made her own enzyme inhibitors for her bachelor’s thesis
For her bachelor’s thesis, Molecular Science and Technology student Madouc Bergers synthesized her own molecule that can inhibit the breakdown of sugars. Although most students do not even manage to make one building block, Madouc made three. Partly because of this, she has been nominated for the Science…
-
Tom van der Wel
Science
t.van.der.wel@lic.leidenuniv.nl | +31 71 527 3527
-
Serkan Aslan
Science
s.aslan@lacdr.leidenuniv.nl | +31 71 527 5919
-
Erik Danen
Science
e.danen@lacdr.leidenuniv.nl | +31 71 527 4486
-
Oude UB
Rapenburg 70, Leiden
-
In conversation with the head of the rodent facility
Before patients can take a pill, scientists often spend years in the lab developing and testing a candidate drug. That often includes experiments with laboratory animals. As head of the rodent facility, Ilze Bot and her colleagues ensure that these experiments are conducted in an ethically responsible…
-
Rob van Wijk
Science
r.c.van.wijk@lacdr.leidenuniv.nl | +31 71 527 4505
-
Farewell symposium Prof. dr. Joke Bouwstra
Valedictory lecture
-
Remarkable PhD research: diagnosing sepsis in premature babies
How can we diagnose the life-threatening condition sepsis in premature babies as quickly and accurately as possible? That is what PhD student Manchu Thangavelu from the Leiden Academic Centre for Drug Research (LACDR) wants to figure out.
-
With this algorithm, new medicines can be found more quickly
Did he dare take a gamble with his PhD research? Jeroen Methorst didn’t have to think long about it. It could fail or turn out very well. The latter is the case. Methorst developed a computer system that helps researchers find the protein they need. ‘Our whole group is now using this program.’ Methorst…
-
Promising new technique to treat cancer receives NWO grant
Biological chemist Nathaniel Martin and his team received an NWO grant to examine how blocking a specific enzyme in our body, NNMT, could be helpful in the treatment of some cancers. Trials with mice have been promising, and together with the Netherlands Cancer Institute, Martin wants to take the next…
-
Await AND anticipate. How the municipality of Amsterdam manages developments in the digital public domain.
The issue of how to deal with a development such as digitalisation in the public domain raises difficult questions for the municipality: who is responsible and when do you intervene?
-
Students seek sustainable solutions for businesses
Master’s students in Industrial Ecology and Governance of Sustainability have helped answer organisations’ questions about sustainability
-
‘Pharmacogenetics will become part of patient care’
Does medicine make patients feel better or worse? We are getting better at predicting this from people’s DNA profiles, says Professor Jesse Swen. ‘It never fails to fascinate me how one DNA base pair can have such a huge effect on treatment with medication and the outcome.’
-
Lipsius
Cleveringaplaats 1, Leiden
-
Welcome to Leiden University
Welcome to Leiden University
-
Gerrard Boot on abuses in parcel industry
Three directors of PostNL have been arrested in Belgium, suspected of human trafficking among other things. Abuses also exist in the Dutch parcel delivery sector. Why does the Netherlands act less firmly?
-
Chemotherapy without side effects? It’s possible, with light
Nausea, neurologic pain and hair loss: some of the severe side effects of chemotherapy. Not necessary, biochemist Liyan Zhang showed. Together with Leiden biologists and others, she achieved great results with a drug that is only active in combination with light. Zhang will defend her PhD on 4 July.
-
Funding for four Leiden studies in the fight against arthritis
Four researchers from Leiden University will receive funding from arthritis foundation ReumaNederland over the next five years. This should facilitate long-term research into arthritis.
-
Read the three most downloaded papers by CADS researchers
Three of our researchers have been awarded a certificate for receiving enough downloads to be in the top 10% of papers in 2022
-
Leiden researchers join forces against tuberculosis
About one and a half million people worldwide die each year from tuberculosis. For thirty years, therapy with antibiotics has been the same, while it takes far too long and can lead to resistant pathogens. Leiden researchers from four institutes are now joining forces to develop more effective and efficient…
-
Fighting gliobastoma brain tumours with two grants
Few researchers see potential in research on glioblastoma, an incurable brain tumour. Alexander Kros brought together colleagues who are up to the challenge. European research funder ERC recently made 10.6 million euros available, a year earlier NWO provided 3 million euros. ‘In six years, we certainly…
-
No higher risk of miscarriage after COVID-19
LUMC research has shown that women who previously had a miscarriage due to COVID-19 are not at increased risk of having another miscarriage or a stillbirth. Nor are preventive drugs needed during the pregnancy.
-
Better treatment of skin diseases thanks to NWA grant of 11.7 million euros
Patients with skin diseases such as eczema and psoriasis, sometimes spend a lifetime searching for the right medication. To help these patients faster and better, scientists across the country are joining forces. The Next Generation ImmunoDermatology (NGID) project, with LACDR professor Robert Rissmann…
-
3 October University: ‘Artificial intelligence is like young people and sex’
‘Everyone’s talking about it, everyone thinks everyone else is doing it, but the reality is disappointing,’ says biochemist Gerard van Westen in his 3 October University lecture in the Van der Werfpark. In the full marquee, he gets a laugh with this suggestion that artificial intelligence is comparable…
-
Podcast: A changing view on psychedelics
We talk with Michiel van Elk, about his research into mapping what effects psychedelics have on the human brain and what this means for the possible clinical application of these drugs. The cognitive psychologist shares his findings with a sober view, bringing critics and fanatics closer together for…
-
Flying taxis: the new kid hovering over the block
The latest innovation in the field of urban mobility could soon be buzzing over our heads. For some, it’s a science fiction dream come true. For others, however, it’s an unwelcome intrusion. ‘It has the potential to be a major development.’
-
ERC grant for Sebastian Pomplun to precisely influence gene expression
In order to stop a whole range of diseases or disorders at their source, you would have to be able to switch certain genes on or off. Sebastian Pomplun wants to develop substances that can do this very precisely. For example, he wants to disrupt cancer processes and make cells produce an important missing…
-
Identifying vulnerabilities and stigmas of children from parents in violent extremist networks
Five questions about PREPARE, the new research project funded by the EU and led by Joana Cook. Cook is Assistant Professor of Terrorism and Political Violence at the Institute of Security and Global Affairs and lead investigator on PREPARE.
-
Renske Donkers wins Young Star Award, students surprise lecturers
Molecular Science & Technology student Renske Donkers has won the second edition of the Young Star Award. During the ceremony on Wednesday 17 February, no less than three teachers were awarded the title 'Teacher of the Year'. Finally, students had a surprise in store for all teachers: with a video they…
-
Vacancy: Student/Program Assistant for the Advanced Master LDT program
Human resources
-
eLaw publishes article in Computer Law & Security Review
In healthcare, gender and sex considerations are crucial because they affect individuals' health and disease differences. Yet, most algorithms deployed in the healthcare context lack close consideration of these aspects and do not account for bias detection. In their latest paper, Eduard Fosch-Villaronga,…
-
Improving nature’s antibiotic
'What nature made isn’t necessarily an optimized medicine to use in the human body,’ says Professor of Biological Chemistry Nathaniel Martin. That’s why a group of Leiden researchers is making a chemistry-based improved version of the frequently used antibiotic vancomycin. They received an NWO NACTAR…
-
Can Parkinson's be stopped by unravelling protein fibres? Anne Wentink finds out with a Vidi grant from NWO
In brain diseases such as Parkinson's and Alzheimer's, proteins clump together to form fibres. ‘Chaperone proteins’ unravel those fibres, but in the test tube biochemist Anne Wentink saw that this can also cause new problems. She is going to find out what happens inside cells to determine what a drug…
-
Looking at the person beyond the blood clot
How can we improve the treatment of thrombosis, reduce the disease’s impact and spend less money while we’re at it? This is what Erik Klok, Professor of Internal Medicine and an internist, is researching. He will discuss it in depth in his inaugural lecture on 10 March.
-
Study associations sign covenant: limit your alcohol consumption and look after each other
Opting more often for mocktails or soft drinks rather than beer or wine, talking to others about their drinking and pointing out the ban on drugs. Leiden University’s new covenant on alcohol and drugs for study associations encourages providing more alcohol-free alternatives.
-
How Europe will be better prepared for the next pandemic
The European PANVIPREP research project started at the Leiden University Medical Center on 11 March. The participants are virologists, biochemists and pharmacists from 14 European countries. Their mission is to develop antiviral drugs to protect Europe during pandemics. At least two such antivirals…
-
Sibel Bahtiri is one of the new Faces of Science: ‘I want to show how we’re finding alternatives to animal testing’
PhD candidate Sibel Bahtiri is one of the new Faces of Science. In videos and blogs, she will show what life is like as a young researcher.
-
On this public day on psychedelics, researchers transcend the media hype
Never before has so much research been carried out on the therapeutic effect of psychedelic drugs. Researchers at the LIBC Public Day are happy about the effect the drugs can have on depression, anxiety and PTSS, but at the same time they have some doubts. ‘The hype is bound to crash before long.’
-
Daniel Carter, PhD – ‘There's “money law” and there's “people law” and I've always been more interested in the latter.’
Not everyone benefits from the increased flexibility in the labour market. EU migrant workers engaged at the lower end of the employment spectrum are falling behind. According to Daniel Carter, the legal system is at fault and in his PhD thesis he explains the reasons why.
- Consent is key